LNP Resources & Expertise
Envol
Why NHP Models Remain Critical for LNP Development and How Envol Is Advancing Translational Confidence
May 8, 2026
Envol
From Design to Delivery: How Envol and the New LNP Alliance Is Solving the Biggest Bottlenecks in Genetic Medicine
May 8, 2026
Envol
Envol Biomedical is Proud to be the Expert NHP Partner in the Launch of the New LNP Alliance
May 8, 2026
NIS
Seeing Through the Fog: Using Cryo-TEM to Characterize LNPs During Formulation and Process Changes
Apr 29, 2026
NIS
Characterization of LNP Payload Distribution and Loading Percentage
Apr 29, 2026
NIS
NIS discusses how cryo-ET can be used to visualize the 3D architecture of complex nanoparticles
Apr 29, 2026
NOF
High-Purity PEG Diacylglycerols for Lipid Nanoparticles | SUNBRIGHT® Series
Mar 24, 2026
NOF
Custom Lipid Synthesis for Pharmaceutical Applications
Mar 24, 2026
NOF
Biodegradable Lipid Nanoparticles for mRNA Delivery and Vaccines
Mar 24, 2026
NOF
Non-viral RNA Delivery with Biodegradable Lipids
Mar 24, 2026
Phosphorex
Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability
Mar 17, 2026
Phosphorex
Optimizing Formulation,Process Design, and CMC to Achieve Target-Appropriate Biodistribution
Mar 3, 2026